Instil Bio, Inc.
TIL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $124 | $50 | $82 | $1,814 |
| - Cash | $9 | $9 | $44 | $38 |
| + Debt | $87 | $86 | $80 | $0 |
| Enterprise Value | $202 | $126 | $118 | $1,776 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | -$6 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$63 | -$147 | -$217 | -$153 |
| % Margin | – | – | – | – |
| Net Income | -$74 | -$156 | -$223 | -$157 |
| % Margin | – | – | – | – |
| EPS Diluted | -11.39 | -24 | -34.46 | -29.6 |
| % Growth | 52.5% | 30.4% | -16.4% | – |
| Operating Cash Flow | -$56 | -$82 | -$180 | -$122 |
| Capital Expenditures | -$10 | -$21 | -$85 | -$58 |
| Free Cash Flow | -$66 | -$103 | -$265 | -$180 |